Merz
is a Germany-based pharmaceutical firm that develops and commercializes neurological therapeutics for patients... Read moreMerz
is a Germany-based pharmaceutical firm that develops and commercializes neurological therapeutics for patients... Read more
News
May 06, 2026
Investing.com
Merz: Merz says transatlantic ties remain strong despite Iran disagreement
Oct 28, 2025
FinanzNachrichten
Merz: Merz Group Expands Management Board: Dr. Almuth Steinkhler Appointed New Chief Financial Officer (CFO)
Jan 06, 2025
FinanzNachrichten
Merz: Generational Transition of Shareholder Leadership in the Family Owned Merz Group
Nov 04, 2024
Pulse2.0
Merz: Vensica Medical: Urology Therapeutics Company Raises $11 Million
Jun 16, 2024
StreetInsider
Press Release: Merz : XEOMIN (incobotulinumtoxinA) receives a new therapeutic indication for Switzerland
May 16, 2024
Bloomberg Law
Merz: Merz Pharma Wins Injunction Against Ex-Employee Who Took Info
Apr 02, 2024
Business Wire India
Merz: Merz Enters Asset Purchase Agreement With a US-Based Biotech Company
Apr 02, 2024
Endpoints News
Merz: Acorda files for bankruptcy, agrees to sell MS drug and other assets to Merz for $185M
Jun 28, 2023
FinanzNachrichten
Merz: Merz Therapeutics Expands Business with New Nordics Affiliate
Jun 08, 2023
Pharamceutical Technology
Merz: UK's MHRA expands approval for Merz Therapeutics' XEOMIN
Merz Competitors
1
2
3
4
5
6
7
8
9
10